Log in to save to my catalogue

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3054431439

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

One of the major determinants of exercise intolerance and limiting symptoms among patients with obstructive hypertrophic cardiomyopathy (HCM) is an elevated intracardiac pressure resulting from left ventricular outflow tract obstruction. Aficamten is an oral selective cardiac myosin inhibitor that reduces left ventricular outflow tract gradients by...

Alternative Titles

Full title

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3054431439

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3054431439

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2401424

How to access this item